Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin

Soft tissue sarcomas (STS) are a group of rare and heterogeneous cancers with few diagnostic or prognostic biomarkers. This metabolomics study aimed to identify new serum prognostic biomarkers to improve the prediction of overall survival in patients with metastatic STS. The study enrolled 24 patien...

Full description

Saved in:
Bibliographic Details
Published in:Cancers (Basel)
Main Authors: Miolo, Gianmaria, Di Gregorio, Emanuela, Saorin, Asia, Lombardi, Davide, Scalone, Simona, Buonadonna, Angela, Steffan, Agostino, Corona, Giuseppe
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7409362/
https://ncbi.nlm.nih.gov/pubmed/32708128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12071983
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items